RT Journal Article
SR Electronic
A1 Alexander, Walter
T1 Effects of Carperitide and Nicorandil on Injury and Function in Patients with Acute MI: Results of the J-WIND Trial
JF MD Conference Express
YR 2006
FD SAGE Publications
VO 6
IS 5
SP 17
OP 20
DO 10.1177/155989770600600509
UL http://mdc.sagepub.com/content/6/5/17.abstract
AB The results of the Japanese Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by Atrial Natriuretic Peptide (ANP) or Nicorandil [J-WIND] trials conducted in Japan from 2001–2006. Carperitide, human recombinant ANP, is approved for the treatment of acute heart failure in Japan. Nicorandil, a nicotinamide nitrate that activates potassium channels in the heart, is used to treat chronic angina. These randomized, double-blind studies evaluated intervention with either carperitide or nicorandil on infarct size, left ventricular function, and associated outcomes.